You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IGR-1R

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Low-Dose Decitabine plus anti-PD-1
  • Beijing, Beijing, China
    ChinaPLAGH
Apr 18, 2023

Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)

Recruiting
  • Non-hodgkin Lymphoma
  • Hodgkin Lymphoma
  • DOC Group B
  • +16 more
  • Valhalla, New York
    New York Medical College
Jun 9, 2022

Aging Trial in Glendale

Withdrawn
  • Aging
  • (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
  • Control
  • Glendale, Arizona
    Glencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023

Bietti Crystalline Dystrophy Trial in Shanghai (VGR-R01)

Not yet recruiting
  • Bietti Crystalline Dystrophy
  • VGR-R01
  • Shanghai, Shanghai, China
    Shanghai Vitalgen Biopharma Co.,Ltd.
Jan 20, 2023

Circulatory Shock and Sepsis (MiMICSS)

Recruiting
  • Sepsis
  • +2 more
  • Skeletal muscle and cerebral NIRS (research device)
  • Winnipeg, Manitoba, Canada
    Health Sciences Centre Winnipeg
Aug 2, 2023

Acute Myeloid Leukemia Trial (WU-NK-101)

Not yet recruiting
  • Acute Myeloid Leukemia
  • WU-NK-101
  • (no location specified)
Jul 20, 2022

Healthy Trial in Seoul (DA-5211, DA-5211-R1 + DA-5211-R2)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    Bumin Hospital
Jun 2, 2022

Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +9 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Linyi, Shandong, China
    Linyi Central Hospital
Jul 25, 2023

Low Risk MDS Trial (R906289 Monosodium (R289 Na))

Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
Jul 22, 2022

Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +8 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Jiangsu, China
    Xuzhou Second People's Hospital
May 8, 2023

Obesity, Hypoglycemia Post Gastric Bypass Surgery, Hyperinsulinemic Hypoglycemia Trial in Arnhem (GLP-1R PET)

Recruiting
  • Obesity
  • +2 more
  • GLP-1R PET
  • Arnhem, Netherlands
    Rijnstate hospital
Oct 27, 2022

PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

Not yet recruiting
  • PD-1 Refractory Advanced Melanoma
  • Responder-Derived Fecal microbiota transplantation (R-FMT
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 1, 2023

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Still's Disease, Adult-Onset Trial in Adelaide (APB-R3, Placebo)

Not yet recruiting
  • Still's Disease, Adult-Onset
  • Adelaide, South Australia, Australia
    CMAX Clinical Research
Jan 27, 2023

Mental Health Issue, Children, Adult Trial in San Diego (After-Action Review)

Active, not recruiting
  • Mental Health Issue
  • Children, Adult
  • After-Action Review
  • San Diego, California
    UC San Diego - IN STEP Children's Mental Health Research Center
Nov 16, 2022

Type 1 Diabetes Trial in Portland (MPC AP algorithm, Robust R-AP algorithm)

Completed
Has Results
  • Type 1 Diabetes
  • MPC AP algorithm
  • Robust R-AP algorithm
  • Portland, Oregon
    Oregon Health and Science University
Jan 3, 2023

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

Trial Readiness and Endpoint Assessment in LGMD R1

Not yet recruiting
  • Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
  • +3 more
    • Richmond, Virginia
      Virginia Commonwealth University
    Jan 10, 2023

    Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, Shanghai, China
      Shanghai Tenth People's Hospital
    Mar 26, 2023

    Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma Trial in Xuzhou (CAR-T Cell Infusion)

    Recruiting
    • Acute T-lymphoblastic Leukemia
    • Acute T-lymphoblastic Lymphoma
    • CAR-T Cell Infusion
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Candidiasis, Vulvovaginal Trial in Winnipeg (Fluconazole 150 mg, Boric Acid Supp,Vag)

    Recruiting
    • Candidiasis, Vulvovaginal
    • Fluconazole 150 mg
    • Boric Acid Supp,Vag
    • Winnipeg, Manitoba, Canada
      Health Science Centre (HSC)
    Jan 31, 2023

    Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome With Excess Blasts-2
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 26, 2023

    Non Small Cell Lung Cancer Trial in Pittsburgh (Fecal Microbiota Transplant (FMT), Pembrolizumab)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Dec 20, 2022

    Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus

    Recruiting
    • Head and Neck Cancer
    • +6 more
    • Recombinant oncolytic herpes simplex virus type 1 (R130)
    • Shanghai, China
      Eye & ENT Hospital of Fudan University
    Apr 13, 2023

    Depression, Anxiety, Quality of Life Trial in Winnipeg (Focused ACT)

    Active, not recruiting
    • Depression
    • +3 more
    • Focused ACT
    • Winnipeg, Manitoba, Canada
    • +2 more
    Nov 1, 2022